EquityZen Growth Technology Fund LLC - Series 2126
Raised
$150K
Investors
14
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2126 is a Delaware-organized pooled investment vehicle filed by EquityZen Advisors LLC and Phil Haslett. The fund raised $150K from 14 investors with a $10K minimum investment, using Rule 506(b) and 3(c)(1) exemptions. It is part of the EquityZen platform, which operates 1889+ EDGAR entities focused on pre-IPO secondary transactions.
This pre-IPO pooled fund follows the standard EquityZen platform template: 506(b) exempt, low minimum investment ($10K), and designed for accredited retail investors seeking exposure to private growth companies. The investor count and raise size are consistent with smaller series tranches within the EquityZen ecosystem.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.